
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Allobarbital
Introduction
Overview
Overview
Allobarbital, also known as allobarbitone and branded as Cibalgine or Dial-Ciba (in combination with ethyl carbamate), is a barbiturate derivative invented in 1912 by Ernst Preiswerk and Ernst Grether working for CIBA. It was used primarily as an anticonvulsant[1] although it has now largely been replaced by newer drugs with improved safety profiles. Other uses for allobarbital included as an adjutant to boost the activity of analgesic drugs, and use in the treatment of insomnia and anxiety.
Allobarbital was never particularly widely used compared to better known barbiturates such as phenobarbital and secobarbital, although it saw more use in some European countries such as Bulgaria and Slovakia,[2] and is still used in for example Poland, but only as compound.[3]
References
References
- ↑ Chocholova L.; Radil-Weiss, T. (1971). “Effect of allobarbital on focal epilepsy in rats”. Physiologia Bohemoslovaca. 20 (4): 325–34. PMID 4335127.
- ↑ Getova, D.; Georgiev, V. (1987). “GABA-ergic mechanisms in the anticonvulsive activity of newly synthesized barbiturates. I. Effects of barbiturates on the convulsive action of GABA-antagonists”. Acta Physiologica et Pharmacologica Bulgarica. 13 (3): 43–50. PMID 3439474.
- ↑ “APTECZKA BABUNI – KROPLE ŻOŁĄDKOWE KROPLE 20 G”. Domzdrowia.pl (in Polish). Archived from the original on October 31, 2007. Retrieved March 10, 2013. Unknown parameter
|trans_title=ignored (help)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
